CCND1 and breast cancer: The goal of the current study is to examine the expression levels of miRNA-373 and VEGF, and cyclin D1 in Egyptian breast cancer patients as minimal noninvasive molecular markers for diagnostic purposes, and their impact on clinical characteristics of breast cancer.